{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:04:42Z","timestamp":1792782282511,"version":"4.5.0"},"reference-count":51,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"KiKa (Children cancer-free) and Vonk (VUmc Onderzoek Naar Kinderkanker)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:p>\n                    Methotrexate (MTX), a folate antagonist which blocks\n                    <jats:italic>de novo<\/jats:italic>\n                    nucleotide biosynthesis and DNA replication, is an anchor drug in acute lymphoblastic leukemia (ALL) treatment. However, drug resistance is a primary hindrance to curative chemotherapy in leukemia and its molecular mechanisms remain poorly understood. We have recently shown that impaired folylpolyglutamate synthetase (FPGS) splicing possibly contributes to the loss of FPGS activity in MTX\u2010resistant leukemia cell line models and adult leukemia patients. However, no information is available on the possible splicing alterations in FPGS in pediatric ALL. Here, using a comprehensive PCR\u2010based screen we discovered and characterized a spectrum of FPGS splicing alterations including exon skipping and intron retention, all of which proved to frequently emerge in both pediatric and adult leukemia patient specimens. Furthermore, an FPGS activity assay revealed that these splicing alterations resulted in loss of FPGS function. Strikingly, pulse\u2010exposure of leukemia cells to antifolates and other chemotherapeutics markedly enhanced the prevalence of several FPGS splicing alterations in antifolate\u2010resistant cells, but not in their parental antifolate\u2010sensitive counterparts. These novel findings suggest that an assortment of deleterious FPGS splicing alterations may constitute a mechanism of antifolate resistance in childhood ALL. Our findings have important implications for the rational overcoming of drug resistance in individual leukemia patients.\n                  <\/jats:p>","DOI":"10.1002\/ijc.29919","type":"journal-article","created":{"date-parts":[[2015,11,8]],"date-time":"2015-11-08T13:54:17Z","timestamp":1446990857000},"page":"1645-1656","source":"Crossref","is-referenced-by-count":41,"title":["Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance"],"prefix":"10.1002","volume":"138","author":[{"given":"Anna","family":"Wojtuszkiewicz","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology VU University Medical Center Amsterdam The Netherlands"},{"name":"Department Of Hematology VU University Medical Center Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shachar","family":"Raz","sequence":"additional","affiliation":[{"name":"Department Of Biology Technion\u2010Israel Institute of Technology Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Stark","sequence":"additional","affiliation":[{"name":"Department Of Biology Technion\u2010Israel Institute of Technology Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda G.","family":"Assaraf","sequence":"additional","affiliation":[{"name":"Department Of Biology Technion\u2010Israel Institute of Technology Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department Of Rheumatology VU University Medical Center Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godefridus J.","family":"Peters","sequence":"additional","affiliation":[{"name":"Department Of Medical Oncology VU University Medical Center Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Sonneveld","sequence":"additional","affiliation":[{"name":"Dutch Childhood Oncology Group (DCOG) The Hague The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertjan J. L.","family":"Kaspers","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology VU University Medical Center Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Cloos","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology VU University Medical Center Amsterdam The Netherlands"},{"name":"Department Of Hematology VU University Medical Center Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.249"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.1031"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02070.x"},{"key":"e_1_2_6_5_1","first-page":"1","volume-title":"Evaluation of folic acid metabolism in health and disease","author":"Stokstad ELR.","year":"1990"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2012.07.002"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.18.5694"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-007-9049-z"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2006.09.001"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)76458-8"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2360193"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118409"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.1.44.44"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(01)00824-3"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1493"},{"key":"e_1_2_6_16_1","first-page":"2548","article-title":"Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug\u2010induced inhibition of de novo thymidylate and purine biosynthesis in","volume":"5","author":"Barnes M","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.5.1677"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2399"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)38101-8"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(96)00057-3"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00135-M"},{"key":"e_1_2_6_22_1","first-page":"566","article-title":"Multifactorial resistance to 5, 10\u2010dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF\u2010CEM","volume":"55","author":"Pizzorno G","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0156"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.06.016"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.11.6903"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-173799"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2008.12.026"},{"key":"e_1_2_6_28_1","first-page":"535","article-title":"Evolution of drug resistance in CCRF\u2010CEM human leukemia cells selected by intermittent methotrexate exposure","volume":"7","author":"McGuire J","year":"1995","journal-title":"Oncol Res"},{"key":"e_1_2_6_29_1","first-page":"2399","article-title":"Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells","volume":"4","author":"Mauritz R","year":"1998","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp215"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2001.4815"},{"key":"e_1_2_6_32_1","first-page":"299","article-title":"Measurement of folylpolyglutamate synthetase activity in head and neck squamous carcinoma cell lines and clinical samples using a new rapid separation procedure","volume":"4","author":"Jansen G","year":"1992","journal-title":"Oncol Res"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-080-5_20"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.38.27018"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.05.026"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-6-31"},{"key":"e_1_2_6_37_1","first-page":"1996","article-title":"Cross\u2010resistance studies of folyl\u2010polyglutamate synthetase\u2010deficient, methotrexate\u2010resistant CCRF\u2010CEM human leukemia sublines","volume":"7","author":"McGuire J","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.16.9579"},{"key":"e_1_2_6_39_1","first-page":"942","article-title":"Folylpolyglutamate synthetase gene mRNA splice variants and protein expression in primary human leukaemia cells, cell lines and normal human tissues","volume":"7","author":"Leclerc G","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M005228200"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2010.04.012"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2921"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00197a023"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.11.5985"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2009.46"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400969"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.39"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2015.993316"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.4.1373"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb1260"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.07.019"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.163444"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.29919","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.29919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T11:51:06Z","timestamp":1695469866000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.29919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1002\/ijc.29919"],"URL":"https:\/\/doi.org\/10.1002\/ijc.29919","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]}}}